Neoplasms, Colorectal Terminated Phase 1 Trials for Nivolumab (DB09035)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02991196Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal CancerBasic Science